Home>>Signaling Pathways>> Stem Cell>> YAP>>TDI-011536

TDI-011536

Catalog No.GC65889

TDI-011536 is a potent Lats kinase inhibitor, interrupts Hippo-Yap signaling and initiates the proliferation of lesioned heartmuscle cells. TDI-011536 can be used in studies of organ conservation and regeneration.

Products are for research use only. Not for human use. We do not sell to patients.

TDI-011536 Chemical Structure

Cas No.: 2687970-96-1

Size Price Stock Qty
10mg
$90.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

TDI-011536 is a potent Lats kinase inhibitor, interrupts Hippo-Yap signaling and initiates the proliferation of lesioned heartmuscle cells. TDI-011536 can be used in studies of organ conservation and regeneration[1].

TDI-011536 (3 µM; 24 h) reduces Yap phosphorylation and (3 µM; 5 days) induces proliferation of MÜller glia in human retinal organoids[1].

Cell Proliferation Assay[1]

Cell Line: human retinal organoids
Concentration: 3 µM
Incubation Time: 24 h, 5 days
Result: Supressed Yap phosphorylation and promoted MÜller glia proliferation.

TDI-011536 (200 mg/kg; i.p.; once) provides over 4 h of Lats inhibition in the liver, heart, and skin and reduces the amount of pYap for at least 4 h after injection in all three organs[1].
TDI-011536 (100 mg/kg; i.p.; once daily for 2 or 3 days) shows proliferative effect on cardiomyocytes[1].

Animal Model: Living mice (immunoblot analysis of the heart, liver, and skin immediately after injection)[1].
Dosage: 200 mg/kg
Administration: Intraperitoneal injections; once.
Result: Reduced the amount of pYap for at least 4 h after injection in all three organs and the levels returned to control values within a day.
Animal Model: Male 8-week-old mice (cryolesion model)[1].
Dosage: 100 mg/kg
Administration: Intraperitoneal injections; once daily for 2 or 3 days.
Result: Promoted cardiomyocytes proliferation.

Reviews

Review for TDI-011536

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TDI-011536

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.